Scientists at the Indian Institute of Technology-Kharagpur have crafted nanoparticles from discarded cataract-affected lens, a development they claim could aid in safe, targeted drug delivery.
The innovative nano-carriers designed by Swagata Dasgupta, faculty at the Department of Chemistry and research schola, Susmitnarayan Chaudhury make use of 'cataractous eye protein isolate' (CEPI) which is the emulsion of aggregated protein mass from the cloudy lens.
"Each day numerous cataract surgeries are performed and the emulsion that is aspirated from the eye discarded. The motivation is related to the use of discarded material for the preparation of the nanoparticles that have the potential to be used in compound/drug delivery," Dasgupta told IANS.
Further, she pointed out, the preparation of CEPI nanoparticles is economical since the emulsion itself from which the nanoparticles are made is discarded waste material.
The nano-carriers' USP lie in their composition.
Dasgupta elaborated: "Being made of proteinaceous material the likelihood of any side effects is expected to be minimal in comparison to biocompatible polymers and its degradation during the release of a compound/drug at the target site will not result in toxic fragments."
A patent has been filed under the title 'Preparation of Nanoparticles derived from cataractous eye Protein isolate'.
--IANS
sgh/pgh/dg
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
